A randomized controlled trial of microdose leuprolide protocol vs. luteal phase ganirelix protocol in predicted low responders.
Phase of Trial: Phase III
Latest Information Update: 30 May 2018
At a glance
- Drugs Ganirelix (Primary) ; Leuprorelin (Primary)
- Indications Female infertility; Infertility
- Focus Therapeutic Use
- 09 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Nov 2009 Planned end date changed from 1 Sep 2009 to 1 Sep 2010 as reported by ClinicalTrials.gov.